J1710 – Injection, hydrocortisone sodium phosphate, up to 50 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ1710
- Long description
- Injection, hydrocortisone sodium phosphate, up to 50 mg
- Short description
- Hydrocortisone sodium ph inj
- Pricing indicator
51Drugs- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1EOther drugs- Added
- January 1, 1982
- Last change
- January 1, 2026 – No change
- Termination date
- December 31, 2025
Frequently asked questions
What is HCPCS code J1710?
J1710 is a HCPCS Level II code for injection, hydrocortisone sodium phosphate, up to 50 mg. It was discontinued on December 31, 2025.
Does Medicare cover J1710?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J1644 – Injection, heparin sodium, per 1000 units
- J1645 – Injection, dalteparin sodium, per 2500 iu
- J1650 – Injection, enoxaparin sodium, 10 mg
- J1652 – Injection, fondaparinux sodium, 0.5 mg
- J1655 – Injection, tinzaparin sodium, 1000 iu
- J1670 – Injection, tetanus immune globulin, human, up to 250 units
- J1675 – Injection, histrelin acetate, 10 micrograms
- J1700 – Injection, hydrocortisone acetate, up to 25 mg
- J1720 – Injection, hydrocortisone sodium succinate, up to 100 mg
- J1725 – Injection, hydroxyprogesterone caproate, 1 mg
- J1726 – Injection, hydroxyprogesterone caproate, (makena), 10 mg
- J1729 – Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg
- J1730 – Injection, diazoxide, up to 300 mg
- J1736 – Injection, meloxicam (delova), 1 mg
- J1737 – Injection, meloxicam (azurity), 1 mg
- J1738 – Injection, meloxicam, 1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.